Cargando…

The emerging role of nebulization for maintenance treatment of chronic obstructive pulmonary disease at home

Inhalation therapy is the cornerstone of chronic obstructive pulmonary disease (COPD) management. However, for many COPD patients who are managed at home, nebulization therapy offers an effective alternative treatment and fulfills the gap of catering to the specific population of patients who are un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Talwar, Deepak, Ramanathan, R., Lopez, Meena, Hegde, Rashmi, Gogtay, Jaideep, Goregaonkar, Geeta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098903/ https://www.ncbi.nlm.nih.gov/pubmed/33687012 http://dx.doi.org/10.4103/lungindia.lungindia_68_20

Ejemplares similares

Perceptions and Attitudes of Patients and Their Family Caregivers on Nebulization Therapy for COPD
por: Dumra, Harjit, et al.
Publicado: (2022)

Role of nebulized glycopyrrolate in the treatment of chronic obstructive pulmonary disease
por: Santus, Pierachille, et al.
Publicado: (2017)

Health-Related Effects of Home Nebulization With Glycopyrronium on Difficult-to-Treat Asthma: Post-Hoc Analyses of an Observational Study
por: Talwar, Deepak, et al.
Publicado: (2020)

Modeling the effectiveness of nebulized terbutaline for decompensated chronic obstructive pulmonary disease patients in the emergency department
por: Gueho, Florian, et al.
Publicado: (2016)

Understanding perception of chronic obstructive pulmonary disease among general practitioners, physicians, and pulmonologists in India: Results from a face-to-face survey
por: Kaur, Ishpreet, et al.
Publicado: (2016)

Revefenacin, a once-daily, long-acting muscarinic antagonist, for nebulized maintenance therapy in patients with chronic obstructive pulmonary disease
por: Hvisdas, Christopher
Publicado: (2021)

Efficacy and safety of nebulized glycopyrrolate for administration using a high efficiency nebulizer in patients with chronic obstructive pulmonary disease
por: Leaker, Brian R, et al.
Publicado: (2015)

Optimization of Nebulized Budesonide in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Zhang, Rui, et al.
Publicado: (2020)

Clinical evaluation of nebulized verapamil in out‐patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease
por: Fahimi, Fanak, et al.
Publicado: (2022)

Bacterial Surface Detachment during Nebulization with Contaminated Reusable Home Nebulizers
por: Harris, Jamie C., et al.
Publicado: (2022)

Readmission Risk in Chronic Obstructive Pulmonary Disease Patients: Comparative Study of Nebulized β(2)-Agonists
por: Bollu, Vamsi, et al.
Publicado: (2016)

Nebulized fentanyl for refractory dyspnea secondary to chronic obstructive pulmonary disease (COPD): A case report
por: Hildreth, Leah, et al.
Publicado: (2020)

Evaluation effects of nebulized gentamicin in exacerbation of chronic obstructive lung disease
por: Soltaninejad, Forogh, et al.
Publicado: (2016)

Effect of Nebulized Verapamil on Oxygenation in Chronic Obstructive Pulmonary Disease (COPD) Patients Admitted to the Intensive Care Unit
por: Pourdowlat, Guitti, et al.
Publicado: (2019)

Nebulized nitroglycerin in the emergency department
por: Ulloa, Nicolas A., et al.
Publicado: (2023)

Maintenance Therapy with Nebulizers in Patients with Stable COPD: Need for Reevaluation
por: Terry, Paul D., et al.
Publicado: (2020)

Dosimetrically administered nebulized morphine for breathlessness in very severe chronic obstructive pulmonary disease: a randomized, controlled trial
por: Janowiak, Piotr, et al.
Publicado: (2017)

Comparison of the Efficacy of Budesonide Nebulizer Suspension and Budesonide Inhalation Suspension in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Emami Ardestani, Mohammad, et al.
Publicado: (2018)

Medication management patterns among Medicare beneficiaries with chronic obstructive pulmonary disease who initiate nebulized arformoterol treatment
por: Celli, Bartolome R, et al.
Publicado: (2019)

Efficiency of Nebulizing Furosemide in the Treatment of Chronic Pulmonary Obstructive Disease: A Systematic Review and Meta-Analysis of Clinical Trials
por: Ghaysouri, Abas, et al.
Publicado: (2020)

Safety and clinical outcomes of remdesivir in hospitalised COVID-19 patients: a retrospective analysis of active surveillance database
por: Gupte, Vaishali, et al.
Publicado: (2022)

Microbial contamination of home nebulizers in children with cystic fibrosis and clinical implication on the number of pulmonary exacerbations
por: Tabatabaii, Seyed Ahmad, et al.
Publicado: (2020)

Glycopyrrolate/eFlow CS: The First Nebulized Long-Acting Muscarinic Antagonist Approved to Treat Chronic Obstructive Pulmonary Disease
por: Pleasants, Roy A.
Publicado: (2018)

A real-world cost-effectiveness analysis of nebulized budesonide and intravenous methylprednisolone in acute exacerbation of chronic obstructive pulmonary disease
por: Gu, Yong-Li, et al.
Publicado: (2022)

Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD
por: Bhattacharya, Amal, et al.
Publicado: (2016)

Case Report: Maintenance of Desensitization to Nebulized Colomycin Over 10 Years
por: Sieber, Justyna, et al.
Publicado: (2021)

Lipid management in India: a nationwide, cross-sectional physician survey
por: Wander, Gurpreet S., et al.
Publicado: (2017)

Efficacy and safety of glycopyrronium/formoterol delivered via a dry powder inhaler in patients with moderate to severe chronic obstructive pulmonary disease: Results from a multi-centre, open-label, randomised study
por: Salvi, Sundeep, et al.
Publicado: (2022)

Heliox-Driven Nebulization Has a Positive Effect on the Lung Function in Lipopolysaccharide-Induced Chronic Obstructive Pulmonary Disease Rat Model
por: Wu, Wenwen, et al.
Publicado: (2016)

Clinical Outcomes Of Using Nebulized Budesonide As The Initial Treatment For Acute Exacerbations Of Chronic Obstructive Pulmonary Disease: A Post-Hoc Analysis
por: Zheng, Jin-Ping, et al.
Publicado: (2019)

Future Trends in Nebulized Therapies for Pulmonary Disease
por: McCarthy, Sean D., et al.
Publicado: (2020)

The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK
por: Edwards, Susan C, et al.
Publicado: (2016)

A 28-day, randomized, double-blind, placebo-controlled, parallel group study of nebulized revefenacin in patients with chronic obstructive pulmonary disease
por: Pudi, Krishna K., et al.
Publicado: (2017)

Comparative analysis of medical expenditure with nebulized budesonide versus systemic corticosteroids in hospitalized patients with acute exacerbations of chronic obstructive pulmonary disease in China
por: Zhang, Jing, et al.
Publicado: (2019)

Evaluation of systemic absorption and bronchodilator effect of glycopyrronium bromide delivered by nebulizer or a dry powder inhaler in subjects with chronic obstructive pulmonary disease
por: Leaker, Brian R., et al.
Publicado: (2019)

Patient-Centered Medical Home in chronic obstructive pulmonary disease
por: Ortiz, Gabriel, et al.
Publicado: (2011)

Influence of Mechanical Ventilation Modes on the Efficacy of Nebulized Bronchodilators in the Treatment of Intubated Adult Patients with Obstructive Pulmonary Disease
por: Lima, Cibelle Andrade, et al.
Publicado: (2023)

Eosinophil values in exacerbation and stable chronic obstructive pulmonary disease and its relationship to maintenance therapy in stable chronic obstructive pulmonary disease patients
por: Fachri, Muhammad, et al.
Publicado: (2023)

Inhaled medical aerosols by nebulizer delivery in pulmonary hypertension
por: Mansour, Heidi M.
Publicado: (2018)

Nebulizers effectiveness on pulmonary delivery of alpha-1 antitrypsin
por: Bianchera, Annalisa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_914qommnaee60bl0htdv3tka0i